15.06.2012 Views

Panalpina Annual Report 2006

Panalpina Annual Report 2006

Panalpina Annual Report 2006

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Consolidated and <strong>Annual</strong> Financial Statements <strong>2006</strong><br />

Available-for-sale financial assets<br />

All non-derivative financial assets that are not categorized as held-for-trading or as originated loans and receivables<br />

are classified as available-for-sale. Available-for-sale financial assets which include equity securities are presented as noncurrent<br />

assets, unless they are expected to be sold within twelve months after the balance sheet date.<br />

Purchases and sales of investments are recognized on the settlement date. Investments are initially recognized at fair<br />

value plus transaction costs for all financial assets not carried at fair value through profit or loss. Financial assets carried<br />

at fair value through profit and loss are initially recognized at fair value and transaction costs are expensed in the income<br />

statement. Investments are derecognized when the rights to receive cash flows from the investments have expired or<br />

have been transferred and the Group has substantially transferred all risks and rewards of ownership. Available-for-sale<br />

financial assets and financial assets at fair value through profit or loss are subsequently carried at fair value. Originated loans<br />

and receivables are subsequently carried at amortized cost using the effective interest method.<br />

Gains or losses arising from changes in the fair value of the financial assets at fair value through profit or loss category,<br />

including interest and dividend income, are charged to the income statement in the period in which they arise.<br />

Changes in the fair value of monetary securities denominated in a foreign currency and classified as available-for-sale are<br />

analyzed between translation differences resulting from changes in amortized cost of the security and other changes in<br />

the carrying amount of the security. The translation differences are recognized in profit and loss, and other changes<br />

in carrying amount are recognized in equity. Changes in the fair value of other monetary securities classified as availablefor-sale<br />

and non-monetary securities classified as available-for-sale are recognized in equity.<br />

When securities classified as available-for-sale are sold or impaired, the accumulated fair value adjustments recognized in<br />

equity are included in the income statement as gains and losses from investments. Interest on available-for-sale investments<br />

calculated using the effective interest method is recognized in the income statement. Dividends on available-for-sale equity<br />

instruments are recognized in the income statement when the Group’s right to receive payments is established.<br />

The Group assesses at each balance sheet date whether there is objective evidence that a financial asset or a group of<br />

financial assets is impaired. In case of equity securities classified as available-for-sale, a significant or prolonged decline<br />

in the fair value of the security below its cost is considered an indicator that the securities are impaired. If any such evidence<br />

exists for available-for-sale financial assets, the cumulative loss – measured as the difference between the acquisition cost<br />

and the current fair value less any impairment loss on that financial asset previously recognized in profit or loss – is removed<br />

from equity and recognized in the income statement. Impairment losses of equity instruments recognized in the income<br />

statement are not reversed through the income statement. Impairment testing of trade receivables is described in sections<br />

the Trade receivables and Impairment of financial assets.<br />

Fair values<br />

The fair value of investments is based on quoted bid prices for exchange traded instruments. For unlisted securities or overthe-counter<br />

transactions, the Group determines the fair value using appropriate valuation techniques (such as net present<br />

value or option pricing models). Those equity investments for which fair values cannot be measured reliably are recognized at<br />

cost less impairment. The Group’s impairment policy is outlined in greater detail in section Impairment of assets.<br />

Impairment of financial assets<br />

The Group assesses at each balance sheet date whether a financial asset or a group of financial assets is impaired.<br />

Assets carried at amortized cost<br />

If there is objective evidence that an impairment loss on loans and receivables carried at amortized cost has been<br />

incurred, the amount of the loss is measured as the difference between the asset’s carrying amount and the present value<br />

of future cash flows discounted at the financial asset’s original effective interest rate. The carrying amount of the asset is<br />

reduced through use of an allowance account. The amount of the loss shall be recognized in the period of loss.<br />

The Group first assesses whether objective evidence of impairment exists individually for financial assets that are<br />

individually significant, and individually or collectively for financial assets that are not individually significant.<br />

If it is determined that no objective evidence of impairment exists for an individually assessed financial asset, whether<br />

significant or not, the asset is included in a group of financial assets with similar credit risk characteristics and the<br />

group of financial assets is collectively assessed for impairment. Assets that are individually assessed for impairment<br />

and for which an impairment loss is or continues to be recognized are not included in a collective assessment of<br />

impairment.<br />

If within a subsequent period, the amount of the impairment loss decreases and the decrease can be related objectively<br />

to an event occurring after the impairment was recognized, the previously recognized impairment loss is reversed. Any<br />

subsequent reversal of an impairment loss is recognized in profit or loss, to the extent that the carrying value of the asset<br />

does not exceed its amortized cost at the reversal date.<br />

<strong>Panalpina</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2006</strong> 83

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!